Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 16 | 2023 | 678 | 2.590 |
Why?
|
| Momordica | 2 | 2023 | 14 | 1.810 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 10 | 2015 | 51 | 1.420 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 214 | 0.900 |
Why?
|
| Plants, Medicinal | 1 | 2023 | 54 | 0.890 |
Why?
|
| Exosomes | 5 | 2016 | 97 | 0.870 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 182 | 0.790 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2016 | 2 | 0.590 |
Why?
|
| Sphenoid Bone | 1 | 2016 | 5 | 0.590 |
Why?
|
| HIV Infections | 6 | 2022 | 2207 | 0.590 |
Why?
|
| Virion | 3 | 2016 | 67 | 0.590 |
Why?
|
| Neurosurgical Procedures | 1 | 2016 | 25 | 0.580 |
Why?
|
| Cyclosporine | 3 | 2005 | 26 | 0.570 |
Why?
|
| Peptide Fragments | 2 | 2015 | 298 | 0.570 |
Why?
|
| Developing Countries | 1 | 2016 | 97 | 0.560 |
Why?
|
| AIDS Dementia Complex | 1 | 2015 | 107 | 0.500 |
Why?
|
| RNA, Viral | 1 | 2015 | 287 | 0.480 |
Why?
|
| Cytokines | 3 | 2016 | 569 | 0.460 |
Why?
|
| Raynaud Disease | 1 | 2012 | 10 | 0.430 |
Why?
|
| Acupuncture Therapy | 1 | 2012 | 13 | 0.430 |
Why?
|
| Proteomics | 2 | 2014 | 302 | 0.420 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1152 | 0.390 |
Why?
|
| Virus Replication | 3 | 2008 | 261 | 0.360 |
Why?
|
| Oocytes | 1 | 2010 | 143 | 0.350 |
Why?
|
| Genes, nef | 2 | 2005 | 5 | 0.330 |
Why?
|
| Drug Resistance, Viral | 2 | 2005 | 60 | 0.300 |
Why?
|
| Cyclophilin A | 2 | 2004 | 14 | 0.290 |
Why?
|
| Cell Line | 9 | 2011 | 1289 | 0.280 |
Why?
|
| Humans | 25 | 2023 | 34853 | 0.270 |
Why?
|
| Simian immunodeficiency virus | 1 | 2005 | 56 | 0.260 |
Why?
|
| Gene Products, nef | 4 | 2005 | 19 | 0.250 |
Why?
|
| Mutation | 3 | 2010 | 1023 | 0.250 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2004 | 8 | 0.250 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 90 | 0.240 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2023 | 54 | 0.230 |
Why?
|
| Apoptosis | 6 | 2008 | 1317 | 0.220 |
Why?
|
| Plant Proteins | 1 | 2023 | 93 | 0.210 |
Why?
|
| Antiviral Agents | 1 | 2022 | 148 | 0.200 |
Why?
|
| Proteome | 2 | 2014 | 132 | 0.200 |
Why?
|
| Plant Extracts | 1 | 2022 | 250 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 968 | 0.160 |
Why?
|
| Uzbekistan | 1 | 2016 | 1 | 0.150 |
Why?
|
| Transfection | 5 | 2013 | 496 | 0.150 |
Why?
|
| Female | 7 | 2016 | 19873 | 0.150 |
Why?
|
| Adult | 4 | 2016 | 11034 | 0.140 |
Why?
|
| Amino Acid Sequence | 6 | 2012 | 1124 | 0.140 |
Why?
|
| Receptors, CXCR4 | 3 | 2008 | 67 | 0.140 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 1490 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2013 | 45 | 0.130 |
Why?
|
| Chiroptera | 1 | 2014 | 20 | 0.130 |
Why?
|
| Seasons | 1 | 2014 | 112 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2016 | 1318 | 0.120 |
Why?
|
| Viral Load | 1 | 2015 | 300 | 0.120 |
Why?
|
| Ovary | 1 | 2014 | 101 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 445 | 0.120 |
Why?
|
| Middle Aged | 3 | 2016 | 9642 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 468 | 0.120 |
Why?
|
| Adiposity | 1 | 2014 | 145 | 0.110 |
Why?
|
| Jurkat Cells | 3 | 2008 | 72 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2016 | 1349 | 0.110 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 49 | 0.110 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 197 | 0.110 |
Why?
|
| Macrophages | 1 | 2015 | 431 | 0.110 |
Why?
|
| Male | 7 | 2016 | 18870 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2011 | 33 | 0.100 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 394 | 0.100 |
Why?
|
| Peptides | 2 | 2011 | 308 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2015 | 386 | 0.100 |
Why?
|
| Child | 2 | 2016 | 2875 | 0.100 |
Why?
|
| Animals | 9 | 2014 | 14307 | 0.090 |
Why?
|
| Transport Vesicles | 1 | 2010 | 20 | 0.090 |
Why?
|
| Young Adult | 2 | 2016 | 4012 | 0.090 |
Why?
|
| Swine | 1 | 2010 | 182 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2128 | 0.090 |
Why?
|
| Adolescent | 2 | 2016 | 5035 | 0.090 |
Why?
|
| Brain | 2 | 2008 | 1268 | 0.080 |
Why?
|
| Achlorhydria | 1 | 2008 | 2 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2012 | 751 | 0.080 |
Why?
|
| Parietal Cells, Gastric | 1 | 2008 | 18 | 0.080 |
Why?
|
| Neurons | 1 | 2015 | 1130 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2008 | 107 | 0.080 |
Why?
|
| Neuroglia | 1 | 2008 | 117 | 0.080 |
Why?
|
| Helicobacter Infections | 1 | 2008 | 74 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2008 | 170 | 0.080 |
Why?
|
| Malaria, Cerebral | 1 | 2007 | 31 | 0.080 |
Why?
|
| Helicobacter pylori | 1 | 2008 | 105 | 0.080 |
Why?
|
| Plasmodium falciparum | 1 | 2008 | 121 | 0.080 |
Why?
|
| Aged | 2 | 2015 | 6448 | 0.080 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 44 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 229 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2005 | 224 | 0.070 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 85 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2008 | 360 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2016 | 1442 | 0.070 |
Why?
|
| Spermatogenesis | 1 | 2007 | 154 | 0.070 |
Why?
|
| DNA, Circular | 1 | 2005 | 7 | 0.070 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2005 | 19 | 0.070 |
Why?
|
| Chimera | 1 | 2005 | 15 | 0.070 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 56 | 0.070 |
Why?
|
| Spermatozoa | 1 | 2007 | 191 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 341 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2008 | 296 | 0.060 |
Why?
|
| Virulence | 1 | 2005 | 221 | 0.060 |
Why?
|
| HIV-2 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Trypanosomiasis, African | 1 | 2004 | 23 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2007 | 562 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2005 | 295 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2008 | 520 | 0.060 |
Why?
|
| Base Sequence | 1 | 2005 | 932 | 0.060 |
Why?
|
| Genes, Viral | 1 | 2003 | 62 | 0.060 |
Why?
|
| Hela Cells | 1 | 2004 | 344 | 0.060 |
Why?
|
| Capsid Proteins | 1 | 2003 | 60 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 72 | 0.060 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2004 | 80 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 2003 | 77 | 0.050 |
Why?
|
| Protozoan Proteins | 1 | 2004 | 170 | 0.050 |
Why?
|
| Mutant Proteins | 2 | 2012 | 48 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 550 | 0.050 |
Why?
|
| Protein Transport | 2 | 2011 | 286 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 413 | 0.040 |
Why?
|
| Protein Binding | 2 | 2013 | 913 | 0.040 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 16 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2008 | 126 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 116 | 0.030 |
Why?
|
| China | 1 | 2015 | 178 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 298 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 490 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 161 | 0.030 |
Why?
|
| Static Electricity | 1 | 2012 | 75 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 376 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 172 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2012 | 257 | 0.030 |
Why?
|
| Amino Acids | 1 | 2012 | 139 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2012 | 207 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 383 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 117 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 1425 | 0.020 |
Why?
|
| Mice | 3 | 2008 | 5668 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1422 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 597 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 26 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2333 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 200 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 901 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 286 | 0.020 |
Why?
|
| Gastritis, Atrophic | 1 | 2008 | 10 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2008 | 49 | 0.020 |
Why?
|
| Calpain | 1 | 2008 | 31 | 0.020 |
Why?
|
| E-Selectin | 1 | 2007 | 19 | 0.020 |
Why?
|
| Ghana | 1 | 2007 | 27 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 14 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 16 | 0.020 |
Why?
|
| Rabbits | 1 | 2008 | 278 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2007 | 38 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2007 | 37 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2007 | 59 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 97 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 185 | 0.020 |
Why?
|
| Immunoassay | 1 | 2007 | 57 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2007 | 50 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2008 | 77 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 153 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2007 | 82 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 310 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 164 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 392 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 2008 | 192 | 0.020 |
Why?
|
| United States | 1 | 2015 | 3894 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 325 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 445 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 707 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 36 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 87 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2005 | 143 | 0.020 |
Why?
|
| Infant | 1 | 2007 | 1014 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2004 | 58 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 91 | 0.010 |
Why?
|
| Cerebellum | 1 | 2004 | 69 | 0.010 |
Why?
|
| Brain Stem | 1 | 2004 | 46 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 132 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 97 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 194 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 1530 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 275 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 649 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 251 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 1149 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 1300 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 1802 | 0.010 |
Why?
|